Company · CIK 1718903
Realm Therapeutics plc
| CIK | 1718903 (SEC EDGAR) |
|---|---|
| Industry (SIC) | 2834 — Pharmaceutical Preparations |
| Incorporated in | X0 |
| Business address | United Kingdom |
| Listed | no ticker on SEC record today |
| First annual or quarterly report | 2019-04-10 |
Offerings
1 registration| Registration | Label and status | First filed | Last event | Filings |
|---|---|---|---|---|
| 333-225121 | 2018-05-23 | 2019-07-31 | 11 |
Filings
13| Filed | Filing | Registration | Accession |
|---|---|---|---|
| 2019-07-31 | EFFECTDeclared effective | 333-225121 | 9999999995-19-001757 |
| 2018-09-24 | EFFECTDeclared effective | 333-225121 | 9999999995-18-002441 |
| 2018-08-22 | EFFECTDeclared effective | 333-225121 | 9999999995-18-002167 |
| 2018-07-03 | EFFECTDeclared effective | 333-225310 | 9999999995-18-001698 |
| 2018-07-03 | EFFECTDeclared effective | 333-225121 | 9999999995-18-001695 |
| 2018-07-03 | 424B4Final prospectus | 333-225121 | 0001628280-18-009057 |
| 2018-07-03 | F-1/AAmendment | 333-225121 | 0001628280-18-009017 |
| 2018-06-29 | F-1/AAmendment | 333-225121 | 0001628280-18-008940 |
| 2018-06-19 | F-1/AAmendment | 333-225121 | 0001628280-18-008006 |
| 2018-06-14 | F-1/AAmendment | 333-225121 | 0001628280-18-007841 |
| 2018-05-30 | F-1/AAmendment | 333-225121 | 0001628280-18-007350 |
| 2018-05-23 | F-1Registration filed | 333-225121 | 0001628280-18-007084 |
| 2018-04-13 | DRSDraft made public | 377-02024 | 0001628279-18-000032 |